Symbols / TCRT Stock $2.58 -3.26% Alaunos Therapeutics, Inc.
TCRT (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. The company develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. It also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Ratings
Current target
$2.58
Low
—
High
—
Mean
—
- Former Alaunos legal chief joins Valion Bio for FDA, CDMO push - Stock Titan Mon, 04 May 2026 20
- MSN Money - MSN ue, 05 May 2026 02
- Director at Alaunos (TCRT) receives 6,032-share stock award - Stock Titan Fri, 01 May 2026 20
- Alaunos Therapeutics Faces Nasdaq Non-Compliance, Delisting Risk - TipRanks Wed, 15 Apr 2026 07
- TCRT Stock Analysis: Alaunos Therapeutics Inc rises 3.15 pct near 3 dollar level - Cổng thông tin điện tử tỉnh Lào Cai Wed, 01 Apr 2026 07
- TCRT Stock Surge: What To Expect Next? - StocksToTrade hu, 09 Oct 2025 07
- symbol__ Stock Quote Price and Forecast - CNN Wed, 27 Mar 2024 07
- Alaunos Therapeutics (TCRT) director receives 6,274-share stock grant in lieu of fees - Stock Titan Fri, 01 May 2026 20
- Alaunos Therapeutics (TCRT) Moat Analysis | Q4 2023: EPS Misses Estimates - Stability Report - Xã Vĩnh Công Wed, 22 Apr 2026 22
- TCRT Forecast — Price Prediction for 2026. Should I Buy TCRT? - Intellectia AI Wed, 04 Jun 2025 18
- Alaunos Therapeutics (TCRT) director awarded 6,515 shares at $2.59 - Stock Titan Fri, 01 May 2026 20
- Non-hormonal obesity pill helps mice lose weight, improve liver health - Stock Titan Mon, 02 Mar 2026 11
- MSN Money - MSN ue, 05 May 2026 23
- Alaunos Therapeutics (NASDAQ: TCRT) details board, pay and ownership in 10-K/A - Stock Titan hu, 30 Apr 2026 21
- Alaunos Therapeutics (NASDAQ: TCRT) faces Nasdaq equity deficiency, delisting risk - Stock Titan Wed, 15 Apr 2026 07
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.01
-50.00%
|
0.01
+100.00%
|
0.01
-99.83%
|
2.92
|
| Operating Revenue |
|
0.01
-50.00%
|
0.01
+100.00%
|
0.01
-99.83%
|
2.92
|
| Operating Expense |
|
4.23
-12.28%
|
4.82
-83.08%
|
28.50
-25.32%
|
38.16
|
| Research And Development |
|
1.36
+276.52%
|
0.36
-97.78%
|
16.28
-34.93%
|
25.02
|
| Selling General And Administration |
|
2.87
-35.72%
|
4.46
-63.50%
|
12.22
-7.02%
|
13.14
|
| General And Administrative Expense |
|
2.87
-35.72%
|
4.46
-63.50%
|
12.22
-7.02%
|
13.14
|
| Other Gand A |
|
2.87
-35.72%
|
4.46
-63.50%
|
12.22
-7.02%
|
13.14
|
| Total Expenses |
|
4.23
-12.28%
|
4.82
-83.08%
|
28.50
-25.32%
|
38.16
|
| Operating Income |
|
-4.22
+12.20%
|
-4.81
+83.11%
|
-28.49
+19.14%
|
-35.24
|
| Total Operating Income As Reported |
|
-4.22
+12.20%
|
-4.81
+85.96%
|
-34.27
+2.39%
|
-35.10
|
| EBITDA |
|
-4.22
+12.31%
|
-4.81
+84.44%
|
-30.90
+2.87%
|
-31.82
|
| Normalized EBITDA |
|
-4.19
+12.95%
|
-4.81
+80.86%
|
-25.13
+21.35%
|
-31.95
|
| Reconciled Depreciation |
|
0.01
+250.00%
|
0.00
-99.91%
|
2.31
-16.09%
|
2.76
|
| EBIT |
|
-4.22
+12.20%
|
-4.81
+85.51%
|
-33.22
+3.92%
|
-34.58
|
| Total Unusual Items |
|
-0.03
|
0.00
+100.00%
|
-5.77
-4441.35%
|
0.13
|
| Total Unusual Items Excluding Goodwill |
|
-0.03
|
0.00
+100.00%
|
-5.77
-4441.35%
|
0.13
|
| Special Income Charges |
|
—
|
0.00
+100.00%
|
-5.77
-4441.35%
|
0.13
|
| Other Special Charges |
|
—
|
—
|
-0.30
-124.06%
|
-0.13
|
| Impairment Of Capital Assets |
|
—
|
0.00
-100.00%
|
4.80
|
0.00
|
| Restructuring And Mergern Acquisition |
|
—
|
0.00
-100.00%
|
1.27
|
0.00
|
| Net Income |
|
-4.18
+10.75%
|
-4.68
+86.68%
|
-35.14
+6.86%
|
-37.73
|
| Pretax Income |
|
-4.18
+10.75%
|
-4.68
+86.68%
|
-35.14
+6.86%
|
-37.73
|
| Net Non Operating Interest Income Expense |
|
—
|
0.00
+100.00%
|
-1.92
+39.09%
|
-3.15
|
| Interest Expense Non Operating |
|
—
|
0.00
-100.00%
|
1.92
-39.09%
|
3.15
|
| Net Interest Income |
|
—
|
0.00
+100.00%
|
-1.92
+39.09%
|
-3.15
|
| Interest Expense |
|
—
|
0.00
-100.00%
|
1.92
-39.09%
|
3.15
|
| Other Income Expense |
|
0.05
-63.16%
|
0.13
+102.81%
|
-4.73
-813.90%
|
0.66
|
| Other Non Operating Income Expenses |
|
0.08
-39.85%
|
0.13
-87.31%
|
1.05
+98.11%
|
0.53
|
| Gain On Sale Of Security |
|
-0.03
|
—
|
—
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-4.18
+10.75%
|
-4.68
+86.68%
|
-35.14
+6.86%
|
-37.73
|
| Net Income From Continuing Operation Net Minority Interest |
|
-4.18
+10.75%
|
-4.68
+86.68%
|
-35.14
+6.86%
|
-37.73
|
| Net Income From Continuing And Discontinued Operation |
|
-4.18
+10.75%
|
-4.68
+86.68%
|
-35.14
+6.86%
|
-37.73
|
| Net Income Continuous Operations |
|
-4.18
+10.75%
|
-4.68
+86.68%
|
-35.14
+6.86%
|
-37.73
|
| Normalized Income |
|
-4.14
+11.41%
|
-4.68
+84.07%
|
-29.37
+22.44%
|
-37.86
|
| Net Income Common Stockholders |
|
-4.18
+10.75%
|
-4.68
+86.68%
|
-35.14
+6.86%
|
-37.73
|
| Diluted EPS |
|
-2.20
+24.66%
|
-2.92
+86.71%
|
-21.97
+13.84%
|
-25.50
|
| Basic EPS |
|
-2.20
+24.66%
|
-2.92
+86.71%
|
-21.97
+13.84%
|
-25.50
|
| Basic Average Shares |
|
1.95
+21.68%
|
1.60
+0.11%
|
1.60
+10.50%
|
1.45
|
| Diluted Average Shares |
|
1.95
+21.68%
|
1.60
+0.11%
|
1.60
+10.50%
|
1.45
|
| Diluted NI Availto Com Stockholders |
|
-4.18
+10.75%
|
-4.68
+86.68%
|
-35.14
+6.86%
|
-37.73
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
2.97
+7.66%
|
2.75
-66.66%
|
8.26
-87.28%
|
64.94
|
| Current Assets |
|
1.99
-27.84%
|
2.75
-66.65%
|
8.26
-84.64%
|
53.80
|
| Cash Cash Equivalents And Short Term Investments |
|
1.39
+26.95%
|
1.09
-82.00%
|
6.06
-84.48%
|
39.06
|
| Cash And Cash Equivalents |
|
1.39
+26.95%
|
1.09
-82.00%
|
6.06
-84.48%
|
39.06
|
| Receivables |
|
0.00
-40.00%
|
0.01
+400.00%
|
0.00
-75.00%
|
0.00
|
| Accounts Receivable |
|
0.00
-40.00%
|
0.01
+400.00%
|
0.00
-75.00%
|
0.00
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Restricted Cash |
|
—
|
—
|
0.00
-100.00%
|
13.94
|
| Other Current Assets |
|
0.60
-63.83%
|
1.66
-24.52%
|
2.20
+175.09%
|
0.80
|
| Total Non Current Assets |
|
0.98
|
0.00
-100.00%
|
0.00
-99.98%
|
11.14
|
| Net PPE |
|
0.09
|
0.00
-100.00%
|
0.00
-99.98%
|
10.60
|
| Gross PPE |
|
0.10
+553.33%
|
0.01
+0.00%
|
0.01
-99.93%
|
20.40
|
| Accumulated Depreciation |
|
-0.01
+53.33%
|
-0.01
-15.38%
|
-0.01
+99.87%
|
-9.81
|
| Properties |
|
—
|
—
|
0.00
|
0.00
|
| Buildings And Improvements |
|
—
|
—
|
0.00
-100.00%
|
2.14
|
| Machinery Furniture Equipment |
|
0.00
-100.00%
|
0.01
+0.00%
|
0.01
-99.57%
|
3.47
|
| Construction In Progress |
|
—
|
—
|
—
|
5.23
|
| Other Properties |
|
0.10
|
—
|
—
|
5.23
|
| Leases |
|
—
|
—
|
0.00
-100.00%
|
9.56
|
| Non Current Prepaid Assets |
|
—
|
—
|
0.00
-100.00%
|
0.04
|
| Other Non Current Assets |
|
0.89
|
—
|
—
|
0.50
|
| Total Liabilities Net Minority Interest |
|
0.81
+17.49%
|
0.69
-64.62%
|
1.96
-92.59%
|
26.38
|
| Current Liabilities |
|
0.81
+17.49%
|
0.69
-64.62%
|
1.96
-91.91%
|
24.17
|
| Payables And Accrued Expenses |
|
0.81
+17.49%
|
0.69
-63.83%
|
1.91
-66.34%
|
5.68
|
| Payables |
|
0.67
+29.26%
|
0.52
-16.23%
|
0.62
-55.65%
|
1.39
|
| Accounts Payable |
|
0.61
+18.80%
|
0.52
-16.23%
|
0.62
-55.65%
|
1.39
|
| Current Accrued Expenses |
|
0.15
-17.05%
|
0.18
-86.43%
|
1.30
-69.80%
|
4.29
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
—
|
0.00
-100.00%
|
0.04
-96.29%
|
1.16
|
| Total Tax Payable |
|
0.05
|
0.00
|
—
|
—
|
| Current Debt And Capital Lease Obligation |
|
—
|
—
|
—
|
17.32
|
| Current Debt |
|
—
|
—
|
—
|
16.77
|
| Other Current Borrowings |
|
—
|
—
|
—
|
16.77
|
| Current Capital Lease Obligation |
|
—
|
—
|
0.00
-100.00%
|
0.56
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
|
0.00
|
0.00
-100.00%
|
2.22
|
| Long Term Debt And Capital Lease Obligation |
|
—
|
—
|
0.00
-100.00%
|
2.19
|
| Long Term Debt |
|
—
|
—
|
—
|
—
|
| Long Term Capital Lease Obligation |
|
—
|
—
|
0.00
-100.00%
|
2.19
|
| Other Non Current Liabilities |
|
—
|
—
|
—
|
0.03
|
| Stockholders Equity |
|
2.15
+4.36%
|
2.06
-67.29%
|
6.31
-83.64%
|
38.55
|
| Common Stock Equity |
|
2.15
+4.36%
|
2.06
-67.29%
|
6.31
-83.64%
|
38.55
|
| Capital Stock |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
-87.50%
|
0.02
|
| Common Stock |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
-87.50%
|
0.02
|
| Preferred Stock |
|
0.00
|
0.00
|
—
|
—
|
| Share Issued |
|
2.35
+46.73%
|
1.60
+0.00%
|
1.60
-0.09%
|
1.60
|
| Ordinary Shares Number |
|
2.35
+46.73%
|
1.60
+0.00%
|
1.60
-0.09%
|
1.60
|
| Additional Paid In Capital |
|
926.77
+0.46%
|
922.51
+0.05%
|
922.07
+0.32%
|
919.17
|
| Retained Earnings |
|
-924.62
-0.45%
|
-920.45
-0.51%
|
-915.77
-3.99%
|
-880.63
|
| Total Equity Gross Minority Interest |
|
2.15
+4.36%
|
2.06
-67.29%
|
6.31
-83.64%
|
38.55
|
| Total Capitalization |
|
2.15
+4.36%
|
2.06
-67.29%
|
6.31
-83.64%
|
38.55
|
| Working Capital |
|
1.18
-43.04%
|
2.06
-67.28%
|
6.30
-78.72%
|
29.63
|
| Invested Capital |
|
2.15
+4.36%
|
2.06
-67.29%
|
6.31
-88.60%
|
55.32
|
| Total Debt |
|
—
|
—
|
0.00
-100.00%
|
19.51
|
| Capital Lease Obligations |
|
—
|
—
|
0.00
-100.00%
|
2.75
|
| Net Tangible Assets |
|
2.15
+4.36%
|
2.06
-67.29%
|
6.31
-83.64%
|
38.55
|
| Tangible Book Value |
|
2.15
+4.36%
|
2.06
-67.29%
|
6.31
-83.64%
|
38.55
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-2.87
+42.29%
|
-4.97
+83.51%
|
-30.14
-3.11%
|
-29.23
|
| Cash Flow From Continuing Operating Activities |
|
-2.87
+42.29%
|
-4.97
+83.51%
|
-30.14
-3.11%
|
-29.23
|
| Net Income From Continuing Operations |
|
-4.18
+10.75%
|
-4.68
+86.68%
|
-35.14
+6.86%
|
-37.73
|
| Depreciation Amortization Depletion |
|
0.01
+250.00%
|
0.00
-99.91%
|
2.31
-16.09%
|
2.76
|
| Depreciation |
|
0.01
+250.00%
|
0.00
-99.91%
|
2.31
-16.09%
|
2.76
|
| Depreciation And Amortization |
|
0.01
+250.00%
|
0.00
-99.91%
|
2.31
-16.09%
|
2.76
|
| Other Non Cash Items |
|
0.38
|
—
|
1.33
-0.52%
|
1.33
|
| Stock Based Compensation |
|
0.41
-4.83%
|
0.43
-84.46%
|
2.80
-20.63%
|
3.53
|
| Asset Impairment Charge |
|
—
|
0.00
-100.00%
|
4.80
|
0.00
|
| Operating Gains Losses |
|
0.03
|
—
|
0.01
+0.00%
|
0.01
|
| Gain Loss On Investment Securities |
|
0.03
|
—
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
—
|
0.00
-100.00%
|
0.01
+0.00%
|
0.01
|
| Change In Working Capital |
|
0.47
+164.88%
|
-0.73
+88.34%
|
-6.25
-818.85%
|
0.87
|
| Change In Receivables |
|
0.00
+150.00%
|
-0.00
-233.33%
|
0.00
-99.73%
|
1.11
|
| Change In Prepaid Assets |
|
0.35
-35.06%
|
0.54
+139.72%
|
-1.36
-256.52%
|
0.87
|
| Change In Payables And Accrued Expense |
|
0.12
+109.57%
|
-1.26
+73.46%
|
-4.76
-587.16%
|
-0.69
|
| Change In Accrued Expense |
|
0.02
+102.06%
|
-1.16
+70.82%
|
-3.99
-497.16%
|
-0.67
|
| Change In Payable |
|
0.10
+197.00%
|
-0.10
+87.06%
|
-0.77
-2992.00%
|
-0.03
|
| Change In Account Payable |
|
0.10
+197.00%
|
-0.10
+87.06%
|
-0.77
-2992.00%
|
-0.03
|
| Change In Other Current Assets |
|
—
|
—
|
0.50
+281.68%
|
0.13
|
| Change In Other Current Liabilities |
|
—
|
0.00
+100.00%
|
-0.14
+74.54%
|
-0.54
|
| Investing Cash Flow |
|
-0.10
|
0.00
-100.00%
|
1.35
+797.41%
|
-0.19
|
| Cash Flow From Continuing Investing Activities |
|
-0.10
|
0.00
-100.00%
|
1.35
+797.41%
|
-0.19
|
| Net PPE Purchase And Sale |
|
-0.10
|
0.00
-100.00%
|
1.35
+797.41%
|
-0.19
|
| Purchase Of PPE |
|
-0.10
|
0.00
+100.00%
|
-0.20
+8.80%
|
-0.22
|
| Sale Of PPE |
|
—
|
0.00
-100.00%
|
1.54
+6608.70%
|
0.02
|
| Capital Expenditure |
|
-0.10
|
—
|
-0.20
+8.80%
|
-0.22
|
| Financing Cash Flow |
|
3.26
|
0.00
+100.00%
|
-18.14
-384.88%
|
6.37
|
| Cash Flow From Continuing Financing Activities |
|
3.26
|
0.00
+100.00%
|
-18.14
-384.88%
|
6.37
|
| Net Issuance Payments Of Debt |
|
—
|
0.00
+100.00%
|
-18.11
-117.27%
|
-8.33
|
| Issuance Of Debt |
|
—
|
—
|
—
|
0.00
|
| Repayment Of Debt |
|
—
|
0.00
+100.00%
|
-18.11
-117.27%
|
-8.33
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Long Term Debt Payments |
|
—
|
0.00
+100.00%
|
-18.11
-117.27%
|
-8.33
|
| Net Long Term Debt Issuance |
|
—
|
0.00
+100.00%
|
-18.11
-117.27%
|
-8.33
|
| Net Common Stock Issuance |
|
1.91
|
0.00
-100.00%
|
0.09
-99.37%
|
14.68
|
| Common Stock Payments |
|
—
|
—
|
0.00
+100.00%
|
-0.04
|
| Repurchase Of Capital Stock |
|
—
|
—
|
0.00
+100.00%
|
-0.04
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
0.00
-100.00%
|
0.02
|
| Net Other Financing Charges |
|
—
|
—
|
-0.12
|
—
|
| Changes In Cash |
|
0.29
+105.91%
|
-4.97
+89.41%
|
-46.93
-103.55%
|
-23.06
|
| Beginning Cash Position |
|
1.09
-82.00%
|
6.06
-88.56%
|
53.00
-30.32%
|
76.05
|
| End Cash Position |
|
1.39
+26.95%
|
1.09
-82.00%
|
6.06
-88.56%
|
53.00
|
| Free Cash Flow |
|
-2.97
+40.31%
|
-4.97
+83.62%
|
-30.34
-3.03%
|
-29.45
|
| Interest Paid Supplemental Data |
|
0.00
|
0.00
-100.00%
|
2.06
-4.97%
|
2.17
|
| Common Stock Issuance |
|
1.91
|
0.00
-100.00%
|
0.09
-99.38%
|
14.72
|
| Issuance Of Capital Stock |
|
3.26
|
0.00
-100.00%
|
0.09
-99.38%
|
14.72
|
| Net Preferred Stock Issuance |
|
1.35
|
0.00
|
—
|
—
|
| Preferred Stock Issuance |
|
1.35
|
0.00
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-05-01 View
- 42026-05-01 View
- 42026-05-01 View
- 8-K2026-04-15 View
- 10-K2026-03-31 View
- 8-K2026-03-02 View
- 42026-01-15 View
- 42026-01-15 View
- 42026-01-15 View
- 8-K2026-01-08 View
- 8-K2025-12-23 View
- 42025-11-26 View
- 42025-11-26 View
- 42025-11-26 View
- 10-Q2025-11-14 View
- 42025-08-20 View
- 42025-08-20 View
- 8-K2025-08-20 View
- 10-Q2025-08-14 View
- 8-K2025-07-22 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|